Systemic Corticosteroid Use in Orbital Lymphangioma
- 1 March 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 17 (2) , 85-90
- https://doi.org/10.1097/00002341-200103000-00002
Abstract
To describe the clinical results of systemic corticosteroid use in a series of patients with orbital lymphangioma. Four patients (two adults and two children) were treated with corticosteroids using intravenous, oral, or both routes for 2 days to a month. Corticosteroids were used with and without other therapies for symptomatic exacerbations. The adults showed more improvement with pain than with swelling, whereas the children had improvement with both the signs and symptoms. There were no complications in any patient. Systemic corticosteroids are a useful therapeutic option for patients with orbital lymphangioma and can be used as an adjuvant treatment to surgery and other modalities. Resolution of symptoms with corticosteroids was expedited compared with the natural history of the disease in the patients studied.Keywords
This publication has 6 references indexed in Scilit:
- Sotradecol (Sodium Tetradecyl Sulfate) Injection of Orbital LymphangiomaOphthalmic Plastic & Reconstructive Surgery, 1999
- Orbital Venous AnomaliesOphthalmology, 1997
- An Analysis of Thirty Cases of Orbital LymphangiomaOphthalmology, 1990
- Conservative Management of Childhood Orbital LymphangiomaOphthalmology, 1989
- Orbital-Adnexal LymphangiomasOphthalmology, 1986
- Surgical Management of Orbital Lymphangioma With the Carbon Dioxide LaserAmerican Journal of Ophthalmology, 1986